Cited by 269Cellular Mechanics and InteractionsCancer Cells and MetastasisTGF-β signaling in diseases

The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.

Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer

Open access

Zhang, Meiling, Zhang, Bin·2025·Experimental Hematology & Oncology

DOI 10.1186/s40164-025-00647-2PMC PMC11984264

Open this paper in CoChat — free account Open PDF

Abstract

Tumor microenvironment (TME) is a complex ecosystem composed of both cellular and non-cellular components that surround tumor tissue. The extracellular matrix (ECM) is a key component of the TME, performing multiple essential functions by providing mechanical support, shaping the TME, regulating metabolism and signaling, and modulating immune responses, all of which profoundly influence cell behavior. The quantity and cross-linking status of stromal components are primary determinants of tissue stiffness. During tumor development, ECM stiffness not only serves as a barrier to hinder drug delivery but also promotes cancer progression by inducing mechanical stimulation that activates cell membrane receptors and mechanical sensors. Thus, a comprehensive understanding of how ECM stiffness regulates tumor progression is crucial for identifying potential therapeutic targets for cancer. This review examines the effects of ECM stiffness on tumor progression, encompassing proliferation, migration, metastasis, drug resistance, angiogenesis, epithelial-mesenchymal transition (EMT), immune evasion, stemness, metabolic reprogramming, and genomic stability. Finally, we explore therapeutic strategies that target ECM stiffness and their implications for tumor progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s40164-025-00647-2

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Schematic illustration of ECM components in normal tissue (left) and the TME (right). Matrix stiffness is mainly related to excessive collagen and HA. Both cytokines or TGFβ are involved in the ECM stiffness process, and LOX is involved in collagen crosslinking. ECM stiffness interacts with tumor cells and stromal cells, thus creating a vicious cycleCC BY · PubMed Central

Fig. 2 Key factors and signaling pathways inducing ECM stiffness. Stiffness activates receptors such as integrin, Piezo, and PDGFR, which sense mechanical signals from the ECM and activate downstream pathways, including FAK/SRC, ERK, AKT, β-catenin, RhoA-ROCK, and YAP/TAZ to induce ECM stiffness enhancement. Stromal cells such as CAF, senescent MSC and factors such as TGFβ and hypoxia play a major role in stiffness-mediated propertiesCC BY · PubMed Central

Fig. 3 Regulation of ECM stiffness on CSCs, MSC, invasion, proliferation, metastasis, and EMT. a. ECM stiffness not only affects the stemness of CSCs but also upregulates the expression of Id1 and Id3 via the TGF-β pathway, enhancing the tumor-initiating capacity of GICs. Additionally, under high-stiffness conditions, MSCs can be induced to an osteogenic phenotype. b. ECM stiffness primarily promotes tumor invasion and proliferation by increasing and activating the FAK/SRC phosphorylation and PI3K signaling pathways. Besides ECM stiffness, the composition of ECM, such as collagen, HA, and FN, can also regulate the migration patterns of tumor cells. c. ECM stiffness promotes tumor metastasis by facilitating the nuclear localization of TWIST1 and the CD36-AKT-E2F3-FGF-2 pathway. Additionally, CAFs, ECs and BMDCs promote the colonization of cancer cells in distant organs by secreting growth factors, angiogenic factors, and MMPs. d. During EMT, the expression of N-cadherin, zinc finger transcription factor family members such as Snail, Slug, and Twist, and MMPs is upregulated, while the expression of E-cadherin is downregulated. ECM stiffness induces Snail expression through multiple signaling pathways, including S100A11 membrane translocation, eIF4E phosphorylation, and TGF-β1 autocrine signaling, thereby promoting EMT effectsCC BY · PubMed Central

Fig. 4 Regulation of ECM stiffness on Angiogenesis, Drug Resistance, Immune Escape and Metabolic Reprogramming. a. ECM stiffness supports the growth and survival of ECs mainly by enhancing the expression of VEGF and its receptors; On the contrary, ECM stiffness can also act as a barrier to ECs migration, and ECM protein fragmentation can also act as an anti-angiogenic agent. b. Matrix stiffness actively removes chemotherapeutic drugs from cancer cells by enhancing the functional activity of MRP1, ABC transporters on the cell membrane, and also acts as a barrier to block drug delivery c. EC stiffness not only acts as a physical barrier to block the infiltration of immune cells into the TME, but also limits the contact of anti-apcs with T cells and regulates the polarization of macrophages. d. Matrix stiffness regulates glycolysis, amino acid metabolism, and lipid metabolism in tumors through multiple mechanismsCC BY · PubMed Central

Fig. 5 The diagram of ECM-targeting treatment. a. Targeting ECM components to reduce matrix stiffness, thereby improving drug delivery and enhancing the infiltration of immune cells within the tumor. b. Blocking downstream receptors associated with ECM stiffness to treat tumorsCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · cited 3×
“Indirect MMP inhibitors include blockade of signal transduction pathways (such as MAPK or ERK pathways [141]), and gene therapy (such as inhibition of miRNA expression [51]) to achieve the inhibition of MMP [142].”
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101 · cited 1×
“For example, breast cancer cells under high tension can enhance integrin-dependent mechanical signaling through the expression of FAK or p130cas, which are two integrin-adhesion focal proteins, and promote the progression of breast tumors [39].”
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
Tensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941 · cited 1×
“For example, breast cancer tissue (5–10 kPa) is stiffer than normal breast tissue (800 Pa) [9].”
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · cited 2×
“CAFs are key components of the TME [128], which can enhance the ECM stiffness by the secretion of collagen and other fibrous macromolecules, as well as the degradation of this network through the release of proteolytic enzymes like MMPs, thereby improving the cellular mobility of the entire ECM…”
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740 · cited 1×
“In certain scenarios, altered metabolic activity resulting from reprogramming can be utilized for diagnosing, monitoring, and treating cancer [101].”
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · cited 1×
“A low number of myofibroblasts in the tumor is also associated with reduced survival in PDAC patients [130].”
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO Reports · doi:10.15252/embr.201439246 · Cited by 2,098 · cited 3×
“The oncogene Ras promotes the ameboid migratory phenotype by stimulating Rho activity, whereas the tumor suppressor p53 reduces tumor cell migration by decreasing RhoA activity [41].”
Influential

Show all 205 references

Sorted by citations

Items 101–200 of 269

Glucocorticoid-Mediated Extracellular Matrix Regulation: Implications for Precision Therapy
Zhu, Y., Zhang, Y., Ju, S., & Jie, L. (2025) · Biomedicines · doi:10.3390/biomedicines13061282 · Cited by 1
“The ECM serves dual roles as a physical constraint and tumor-promoting scaffold in cancer progression [47].”
Decoding EMT through liquid biopsy: A path to early detection and targeted therapy
Boyina, R., Desu, P. K., Kosanam, S., Rapuri, A., Alluri, R., Shankaraswamy, J., Mavulati, S. C., & Vanitha, K. (2025) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2025.100141 · Cited by 1
The role of cytokines in ovarian cancer drug resistance
Wang, L., Zang, Y., Dejenie, R., Bing, J., Dong, S., Zhang, Y., Zhu, Y., & Li, J. (2025) · International Journal of Cancer · doi:10.1002/ijc.70099 · Cited by 5
“123 The engagement of integrin β 1 subsequently activates downstream mechanotransduction pathways, including focal adhesion kinase (FAK), Src, and the Rho/ROCK axis.”
Effect of Inertial Cavitation by Ultrasound Active Silica Nanoparticles on 2- and 3D Cellular Systems
Curry, S. D., Alina, T. B., Saemundsson, S. A., Rodríguez, M. C., Bower, B. M., Cha, J. N., & Goodwin, A. P. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c04443 · Cited by 1
Mechanical force sensitive pioneer transcription factors and super-enhancers
Pu, Y. D., Lu, C., Peng, Q., & Qiu, J. (2025) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2025.107247 · Cited by 1
Glycolytic Reprogramming in Uterine Fibroids: Genetic, Transcriptomic, Proteomic, and Metabolomic Insights
Sayed, S. E., Pan, A., Vanos, V., Michel, R., & Borahay, M. A. (2025) · Genes · doi:10.3390/genes16111268 · Cited by 3
Artificial Intelligence in Collagen‐based Biomaterials
Akhter, Z., & Prabakar, S. (2025) · ChemistrySelect · doi:10.1002/slct.202504704 · Cited by 1
Matrix stiffness modulates YAP-mediated glycolysis and proliferation in human corneal endothelial cells
Zhong, M., Zhao, J., & Fan, T. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214594 · Cited by 1
Emerging strategies in engineering nanomaterials for overcoming cancer stem cell-mediated therapy resistance
Huang, C., Ning, X., Liu, T., Li, X., Ullah, M. W., Yang, K., & Lv, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.171087 · Cited by 1
Mechanobiological modulation of extracellular vesicle function and transport dynamics in cancer progression
Ahmad, R., Eldosougi, S., & Stott, S. L. (2025) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2025.100636 · Cited by 2
Cancer-Associated Fibroblasts and Epithelial–Mesenchymal Transition as Critical Contributors to Renal Cell Carcinoma Progression
Vernygorodskyi, S. V., Tonchev, A. B., Evtimov, N., & Bratoeva, K. Z. (2025) · Journal of Molecular Pathology · doi:10.3390/jmp6040031 · Cited by 1
“Importantly, the HGF/c-MET axis induces EMT by upregulating EMT transcription factors like Snail, Slug, and Twist while downregulating epithelial markers such as E-cadherin, thus enhancing invasion, metastasis, and therapy resistance [31,33].”
Evaluation of Metaplastic Triple-Negative Breast Cancer Extracellular Matrix Structure and Protein Composition
Savoie, J. J., Hebert, K., King, C., McConnell, E. C., Hoang, V. T., Monroe, W. T., Burow, M. E., Collins-Burow, B., Belgodere, J. A., & Martin, E. C. (2025) · Bioengineering · doi:10.3390/bioengineering13010047 · Cited by 1
The unseen architects of metastasis: coagulation factors in pre-metastatic niche development
Huang, H., Lu, X., Liu, Y., Zhang, Y., Zhan, J., Zeng, W., Sun, C., Li, B., Zhang, Y., Wang, Q., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02727-0 · Cited by 2
“EMT is essential for tumor metastasis, with E-cad-herin, N-cadherin, and vimentin as key markers [148].”
Targeting stromal cells to overcome immunotherapy resistance in solid tumors
Cheng, S., Hua, Y., Liao, Q., & Liu, Q. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105221 · Cited by 1
Targeted therapies in lung cancer: personalizing treatment across the age spectrum
Xu, Y., Chen, F., Zhang, H., & Wang, X. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1743620 · Cited by 1
“These changes also trigger the differentiation of ﬁ broblasts into myo ﬁ broblasts via TGF-b and PDGF, creating a vicious cycle of ﬁ brosis and ECM deposition that reinforces immune exclusion (78).”
Bone Marrow Stromal Cell Antigen 2 Promotes Esophageal Squamous Cell Carcinoma Progression by Mediating the Cell-Cell Interaction between Cancer Cells and Cancer-Associated Fibroblasts
Torigoe, R., Koma, Y., Nomura, N., Yokoo, H., Omori, M., Nakanishi, T., Miyako, S., Nakanishi, T., Kodama, T., Shigeoka, M., et al. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.01.012 · Cited by 1
“9 Furthermore, CAFs secrete matrix metal-loproteases and other proteases that degrade the extracellular matrix, facilitating tumor invasion and metastasis.”
MicroRNA–VEGF axis in gastric cancer: a novel therapeutic frontier
Al-Omari, L., Abdulsahib, W. K., Jyothi, S. R., Nayak, P. P., Chauhan, A. S., Singla, S., Sead, F. F., & Polatova, D. (2026) · Discover Oncology · doi:10.1007/s12672-026-04724-8 · Cited by 1
Matrix stiffness-induced YEATS2 drives HCC progression via epigenetic activation of the TGFBR2-TAZ-AKT pathway
Zhang, Y., Cao, L., Xiao, W., Zhou, L., Zhao, W., He, M. Q., Tong, J., Wu, Q., Umar, M., Qian, J., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01697-7 · Cited by 1
“QT2024276), and written informed consent was obtained from all participants prior to inclusion in the study.”
Digital spatial profiling uncovers transcriptomic features of distinct plasma cell–like phenotypes in diffuse large B-cell lymphoma
Xie, Z., Qin, Y., Xue, X. M., Chen, X., Xie, T., Zhu, H., Huang, L., Yang, S., Yang, J., Liu, P., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025018014 · Cited by 1
Perineural invasion: A neuroimmune axis mediating immunotherapy resistance across malignancies
Guo, J., Hu, Z., Wu, L., Liu, L., Li, Z., Xiong, L., & Yu, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116636 · Cited by 1
Mechanobiology of non-small cell lung cancer: bridging tumor mechanics and therapeutic strategies
Joshi, R. D., Patil, D. T., & Yadav, K. S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11852-5 · Cited by 1
Is there a link between fascia and cancer? From potential mechanisms to future treatment options
Otto, S., & Klingler, W. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1741526 · Cited by 1
“Emerging strategies aim to restore or normalize tissue stiffness to improve disease outcomes and regenerative capacity (Mai et al., 2024; Thomas et al., 2022; Zhang and Zhang, 2025; Martinez-Vidal et al., 2021; Han et al., 2024).”
Influential
Overcoming Biological Barriers and Drug Resistance Through Next-Generation Nanotherapeutic Delivery in Gastric Cancer
Rahaman, Jalouli, M., Harrath, A. H., Choi, J., Choi, M., Kim, H. S., Park, S., Shim, B., Rani, A., & Kim, B. (2026) · Cells · doi:10.3390/cells15100850 · Cited by 1
“Cancer-associated fibroblasts and extracellular matrix (ECM) proteins promote tumor progression by augmenting cancer cell survival and restricting anti-tumor drug diffusion [39].”
Cell Mechanics in Cancer: Integrating Mechanotransduction Pathways Within the Tumor Microenvironment
Sevgi, M., Işık, Y., Karaca, C., Caglar, E., Abdioğlu, H. B., Zendel, F., Başbınar, Y., & Üvet, H. (2026) · Journal of Cellular Physiology · doi:10.1002/jcp.70184 · Cited by 1
“Enzymes of the lysyl oxidase (LOX) and LOX‐like (LOXL) families, triggered by transforming growth factor beta (TGF‐β) and hypoxia (hypoxia‐inducible factor 1‐alpha, HIF‐1α), govern collagen cross‐linking to reinforce this stiff mechanical barrier (Zhang and Zhang 2025).”
TNNT3 as a candidate node in breast cancer mechanobiology: current evidence, mechanistic models, and key knowledge gaps
Wei, L.-Y., Qi, L., Yu, X., Shi, A., & Zhu, Z. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1836170 · Cited by 1
“It may also influence mechanosensitive transcriptional programs such as YAP/TAZ, with potential consequences for tumor-cell migration, invasion, and therapeutic response (Zhang and Zhang, 2025).”
Multitargeted nanoparticles inhibit cancer invasion by disrupting cancer-associated fibroblast-tumor cell crosstalk and modulating collagen pattern and EMT
Wang, L., Zhi, P., Alradwan, I. A., He, C., Abbasi, A. Z., Gao, H., Rauth, A. M., Cescon, D. W., Henderson, J. T., & Wu, X. Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04526-8 · Cited by 1
“Given that ECM stiffness is a key regulator of EMT, this remodeling provides a mechanistic link to the observed increase in E-cadherin and decrease in N-cadherin and MMP-9 expression [65, 66].”
Targeting the YAP-mediated stromal signaling unlocks chemoresistance in a human organoid fibrosis model
Xiong, D., Zheng, Q., Chen, W., Li, M., Chen, Y., Zhang, C., & Liu, J. (2026) · Biofabrication · doi:10.1088/1758-5090/ae6f84 · Cited by 1
“The fibrotic tumor microenvironment, characterized by pathological accumulation and cross-linking of ECM, is a hallmark of malignancies and is strongly associated with therapeutic resistance and poor prognosis across diverse cancer types [46, 47].”
The Biomechanics of Glioblastoma: Why Glioblastoma Models and Clinical Reality Diverge
Köpke, K., Zuhorn, I. S., & Kruyt, F. A. E. (2026) · Cells · doi:10.3390/cells15100876 · Cited by 1
The mechano-immunological landscape in the tumor microenvironment: From mechanical sensing to a new therapeutic paradigm
Li, W., Xin, Y.-Y., Jin, M.-Z., & Jin, W.-L. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103317 · Cited by 1
“For example, YAP/TEAD inhibition to downregulate PD-L1 can lead to compensatory upregulation of TIM-3 and LAG-3, driven by residual mechanical stress [190].”
Gene dependency-informed inference of response to targeted cancer therapies
Bhattacharjee, N., Peela, S. C. M., Halder, A., Mathew, B., Samanta, S., Gujral, S., Kumari, S., Panda, S., Ganguly, R., Ahuja, G., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73977-2 · Cited by 1
“7l) 75 – 77 .”
Reprogramming the Tumor Oncobiosphere: Bioactive Nanohybrid Materials for Reversing Therapeutic Pseudo-Resistance
Rejinold, N. S., Jin, G., & Choy, J. (2026) · ACS Omega · doi:10.1021/acsomega.6c00998 · Cited by 1
“57,133,134 These processes are orchestrated through MAPK signaling (ERK, JNK, p38, ERK5), which controls ECM remodeling and endothelial behavior.”
Modeling cancer with bacteria-integrated tumor microenvironments using biomaterials: Emerging concepts and opportunities
Jeon, K., Kim, U., Ji, C.-H., Kamaraj, M., Laird, N. Z., Wang, Z., Yu, H., Ermis, M., Sullan, R. M. A., Shen, X., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103330 · Cited by 1
Hybrid movement strategies in orthopedic oncology: Mechanistic integration of musculoskeletal and tumor–host interactions
Wang, D., & Li, Y. (2026) · Seminars in Oncology · doi:10.1016/j.seminoncol.2026.152516 · Cited by 1
Membrane mechanics as critical quality attributes in liposomal drug delivery: linking bilayer structure, mechanics, and performance
Maheshwari, N., Ghode, P., & Maheshwari, R. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127116 · Cited by 1
Extracellular matrix stiffness in chronic liver disease: From mechanisms to treatments
Xi, Z.-H., Sun, W.-J., Li, M., Dong, Q.-Q., Dong, X., Qiao, Z.-L., Tao, H., Yang, J., & Lu, C. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118194 · Cited by 1
Tumor-associated fibrosis plays a role in cellular immunity across human diseases
Tian, M., Lian, M., Zheng, L., Li, Y., Xue, X., & Zhang, Z. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119730 · Cited by 1
Cancer-Associated Fibroblast Heterogeneity and Extracellular Matrix Remodeling as Orchestrators of Drug Resistance in Upper Gastrointestinal Cancers: Insights from Spatial Multi-Omics and Therapeutic Implications
Mirzabeigi, Y., Youssef, J., Gonzalez, J. S., Martinez, T., Avellan, R., Wong, A. G., Perez, M., Carvajal, L. L., Abou-Kheir, W. G., & Bahmad, H. F. (2026) · Cancers · doi:10.3390/cancers18142358 · Cited by 1
“Increased ECM stiffness not only serves as a physical barrier to drug delivery but also alters intracellular signaling pathways, promoting chemoresistance [19].”
Cancer-associated fibroblasts in the lung cancer microenvironment from multi-dimensional mechanisms to therapeutic strategies
Feng, Y., Gu, L., Jia, Z., Zhang, C., & Zhu, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1866753 · Cited by 1
“In vitro matrix models, CAF-tumor cell co-culture systems and animal models have shown that ECM stiffness, integrin signaling, FAK/Src activation, RhoA/ROCK signaling and YAP/TAZ activity can promote matrix remodeling and tumor invasion (34, 47 – 49).”
Engineering ECM-Responsive Nanomedicine to Overcome Tumor Stromal Barriers
Swain, K., & Pattnaik, S. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c01118 · Cited by 1
Extracellular matrix stiffness and mechanotransduction in cancer drug resistance
Song, Y., Huang, C., Han, J., Wang, S., Liu, H., Li, Y., Jiang, Z., Tan, X., Wu, T., & Jiang, F. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101470 · Cited by 1
3D-printed niche-matched GelMA-dECM bioinks rewire lipid metabolic reprogramming and chemosensitization in pancreatic ductal adenocarcinoma
Zhu, B., Yang, T., Chang, M., Li, Y., Wu, D., Yan, J., Guo, Q., Wan, J., Guo, Y., & Lu, Y. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124566 · Cited by 1
Cancer-associated adipocytes: metabolic reprogramming, crosstalk and therapeutic implications in tumor progression
Shi, J., Abdel-Ghany, S. E., Abdelfattah, M. M., Hu, X., Wadan, A. S., & Sabit, H. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02820-3 · Cited by 2
“3,142 While these tissue-scale programmes govern dormancy and metastatic outgrowth, their baseline is set systemically: obesity and chronic low-grade in ﬂ ammation precondition adipose depots and immune tone, accelerating CAA formation and amplifying the very signals reviewed above.”
Hydrogel-based smart bioinks for 3D bioprinting: design strategies and applications in brain tissue engineering and tumor microenvironment modelling
Aundhia, C. J., Desai, J., Patel, S., Talele, C., & Prajapati, B. G. (2026) · Bioimpacts · doi:10.34172/bi.33650 · Cited by 1
Integrative systems biology, transcriptomic profiling, and experimental validation reveal enterolactone as a multi-target inhibitor of metastatic signalling in triple-negative breast cancer
Mahajan, A. S., Patil, R. B., Jagtap, A., Wagh, G., Deotare, A., Hegde, M. V., & Mali, A. V. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118437 · Cited by 1
Mechanical Stiffening Promotes Growth, Invasion, and Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitor Resistance in 3D Plexiform Neurofibroma CulturesPreprint
Ji, K., Shi, C., & Zhang, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.26.701794 · Cited by 1
“These stiffness values were selected based on prior mechanobiology studies in multiple tumor models [22,33] , where matrices in the ~1–2 kPa range are commonly used to represent physiologically soft tissues, whereas matrices in the ~5– 10 kPa range are widely employed to model fibrotic or…”
Influential
Bit1 promotes the progression of gastric cancer by facilitating epithelial–mesenchymal transition and alleviating apoptosis
Huang, L., Xu, M., Zhao, X., Yu, H., Liu, L.-Z., Cao, W., Gui, L., Wu, Z., Zhang, Y., & Li, F. (2025) · Medical Oncology · doi:10.1007/s12032-025-02781-7
“EMT is the transformation of epithelial cells into mesenchymal cells, which is associated with tumor initiation, invasion, metastasis, and resistance to therapy [18, 31].”
Microneedle Patch-Aided Intratumor Co-Delivery of FOLFIRINOX, Surufatinib and αPD-1 for Synergistic Efficacy of Combined Chemo- and Immuno-Therapy of PDACPreprint
Kong, T., Xu, X., Wu, C., Qiu, Z., Hu, B., Qi, Z., Dong, H., Wu, F., Jin, T., Zheng, Y., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5367161
ECM-stiffness mediated persistent fibroblast activation requires integrin and formin dependent chromatin remodelingPreprint
Packirisamy, S., André, O., Fan, Z., Nordenfelt, P., & Swaminathan, V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.16.676527
Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity
Feldman, M., Rotenberg, N., & Shifman, J. M. (2025) · Biomolecules · doi:10.3390/biom15101470
Herbal Nanotherapeutics: A Targeted Approach to Modulating the Tumor Microenvironment for Enhanced Antitumor Efficacy
Kumari, P., & Kumar, S. (2025) · ChemistrySelect · doi:10.1002/slct.202503162
Improving neuroblastoma therapy with a new p53 family-activating agent
Almeida, J., Resende, D. I. S. P., da Silva, R. D. F., Villasante, A., Murphy, C., Zingales, V., Palmeira, A., Škoda, J., Broso, F., Vadivellu, A., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178295
Tumor-on-Chip as a Personalised Platform for Rapid Drug-Testing in Breast CancerPreprint
Helal, C., Pinon, L., Jin, J., Schintu, N., Vazquez, A., Nurmik, M., Antonelli, G., Simon, M., Montaudon, É., Sourd, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.26.684605
MEX3A control of mitochondrial fitness is essential for ovarian clear cell carcinoma tumorigenesis and liver metastasisPreprint
Vinothkumar, P., Lin, P.-Y., Cheng, L.-T., Yu, C.-H. A., Hsu, P., Chou, Y., & Hwang‐Verslues, W. W. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.05.686880
“Depending on the cell type and context, the stiff microenvironment can either promote mitochondrial fusion or induce mitochondrial fission (19,20) to facilitate cancer cell proliferation, invasion, migration, metastasis and drug resistance (21).”
Exploring the prognostic value of the magnesium–immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving Nivolumab
Kitaplı, S., Akpunar, M., Alkan, A., & Tanrıverdi, Ö. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04147-x
Hybrid calcium carbonate nanoparticles incorporated with capsaicin for tumor therapy via calcium overload mediated mitochondria damage and endoplasmic reticulum stress
Li, Y., Zhang, Y., Chen, G., Liu, X., Xia, Q., Li, Y., Yang, J., Xu, G., Chen, J., Chen, J., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.171551
Investigating therapeutic potential of Evodiamine by identifying differentially expressed genes in cisplatin resistance non-small cell lung cancer
Patra, S. K., Pradhan, S. K., Ansari, Z. A., & Biswal, B. K. (2025) · Medical Oncology · doi:10.1007/s12032-025-03178-2
“…the literature that the involvement of COL3A1 , TGM2 , MMP1 , and SLPI genes in extracellular matrix pathways has a role in facilitating tumor progression through ECM degradation and remodelling [32]. and the proteins are IL1B, COL3A1, TGM2, MMP1, CD24, IGFBP3, ZEB2, DSP, SLPI, and PDK4 (Fig.”
Digital Twin Meets the Bench: Natural Compounds Reshape the Ovarian Cancer Microenvironment
Kleczka, A., Dzik, R., & Kabała‐Dzik, A. (2025) · Biomedicines · doi:10.3390/biomedicines13123119 · Cited by 1
“Increased stiffness has been linked to enhanced tumour cell proliferation, invasion, and immune exclusion via mechanotransduction pathways (integrin–FAK, YAP/TAZ) [22,89,90].”
Tumor Microenvironment: Current Understanding and Therapeutic Implications in Adult and Pediatric Cancers
Batra, S., Prabhakar, P., Mohapatra, D., George, N. G., Goel, N., Rishi, B., Misra, A., & Singh, A. (2025) · Onco · doi:10.3390/onco6010002
“…glioblastoma or colorectal cancer can present hypermutated profiles resembling adult tumors [5,39], most pediatric tumors— including fusion-driven cancers—have distinct stromal and ECM characteristics shaped by developmental biology rather than accumulated damage [4,40–42].”
Pancreatic Lipase Inhibition and Cytotoxic Profiling of GC-MS Characterized Pisonia grandis R.Br Leaves Ethanol Extracts Using Cell Line Models and EtBr Staining
Leebana, M., & Prathyusha., P. (2025) · Oriental Journal Of Chemistry · doi:10.13005/ojc/410621
Role of Tumor Microenvironment in Metastatic Breast Cancer
Kaçaroğlu, D., & Gürbüz, N. (2026) · Springer eBooks · doi:10.1007/978-981-95-3682-5_3
Probing cell mechanical properties under zinc oxide nanoparticle exposure using atomic force microscopy
Mathumitha, S., Mahalakshmi, B., Manivannan, J., & Sivasubramanian, J. (2026) · Next Materials · doi:10.1016/j.nxmate.2026.101689
Evaluation of the location and probability of acoustic cavitation in healthy and cancerous 3D cell cultures
Rawnaque, F. S., & Simon, J. C. (2026) · Ultrasonics · doi:10.1016/j.ultras.2026.107999
COMP – PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells
Παπαδάκος, Κ. Σ., Gorji‐Bahri, G., Gradjan, L., Zajac, J., Gil, K., Nduku, Y. T., & Blom, A. M. (2026) · Molecular Oncology · doi:10.1002/1878-0261.70221 · Cited by 1
“Changes in ECM composition, stiffness, and organization can directly inﬂuence EMT, cell motility, and metastatic dissemination [46].”
Commentary: Novel mtDNA methylation-associated prognostic signatures in colorectal cancer
Jiang, X., Zhang, X., & Wang, M. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1780394
“In CRC, dysregulated ECM remodeling in ﬂ uences metastatic potential and clinical outcomes by altering matrix composition and stiffness, and by engaging cell surface receptors such as integrins to activate downstream signaling networks that drive malignancy and therapeutic resistance (8, 9).”
Deep learning enables feature extraction of 3D collagen architecture in cleared fibrotic tissuesPreprint
Houbart, W., Schelfaut, L., Vavladeli, A., Borges, N., Boelens, M., Gomez, C. M. B., Verstappe, B., Ghiasloo, M., Vladimirov, N., Blondeel, P. N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.25.707675
Nanoscale opportunities in extracellular matrix mimicry
Lyon, L. A., Caine, A., Narbay, E., & Cárdenas‐Vásquez, E. D. (2026) · Nanoscale Horizons · doi:10.1039/d5nh00735f
Dual-transferred atmospheric-pressure plasma jet modulates matrix metalloproteinase expression in breast cancer stem cells
Soulat, A., Mohsenpour, T., & Roshangar, L. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102527
“These effects help restore the balance between MMPs and their inhibitors (TIMPs), stabilizing ECM integrity [52,53].”
Cancer-Associated Fibroblasts in Non-Small Cell Lung Carcinoma: Recent Progress and Future Perspectives on Potential Targets and Therapeutic Agents
Aseeri, A. A., AlKhafaje, Z., Hussein, U. A.-R., Adel, Z., Alkadir, O. K. A., Aldulaimi, A., Saeed, S. M., Taher, W. M., Alwan, M., & Smerat, A. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10504-2
“Conversely, elevated TGF-β, α-SMA, and collagen modules may favor anti-fibrotic or matrix-softening strategies [ 138].”
Authors’ Response to Peer Reviews of “Localized Immune Cascade Programming in Desmoplastic Tumors: In Silico Modeling and Validation Study”
Novruzov, M., Mammadova, M., Raval, K. Y., Khan, W. U., & Shiraliyeva, U. (2026) · JMIRx Bio · doi:10.2196/91528
“The following needs to be revised in the Introduction: “...(ECM) [6,7,32,33].... (ICIs) [13,14,15]....exposure [1,2,4,5,9,10,11”
Molecular mechanisms and key pathways for treatment of myopia using Glycyrrhiza glabra (licorice): network pharmacology and molecular docking approaches
Murthy, M. K. (2026) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-026-00750-2
“…to MAPs, have been implicated in tissue stiffening and patho - logical remodeling in fibrosis and cancer (Tomuleasa et al. 2024; Odell et al. 2025; Zhang and Zhang 2025), adding to the notion that myopia has some common characteristics with chronic tissue remodeling disorders (Yin and Ge 2025),…”
Predictive Biomarkers
Ramezani, S. R., & Mojra, A. (2025) · National and International Iranian Conference on Biomedical Engineering (ICBME) · doi:10.1109/icbme68496.2025.11392566
Decoding the metabolic-immune axis for novel therapeutics in bladder cancer
Zhou, M., Xue, X., Li, H., Chen, Z., Nie, Q., & Lai, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189569
Autophagy in cancer-associated fibroblasts: its role in gastrointestinal cancers
Kuppala, V., Chintapudi, H., Gopalaiah, K., Nagaraju, G. P., & El‐Rayes, B. F. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02626-5
“In cancer, CAF-facilitated ECM stiffness mediated by collagen I crosslinked through LOX [56] and deposition of collagens VI, XI, XXII, and XXIV triggers mechano transduction pathways like YAP/TAZ, which strengthen cytoskeletal contractility through ANLN [57], DIAPH3, and drive a positive feedback…”
The rise and evolution of cancer mechanobiology: a bibliometric trajectory of three decades of research
Liu, B., Liu, X., Wang, Y., Han, X., & Dang, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1699709 · Cited by 1
Extracellular matrix polysaccharides and glycoproteins in ovarian cancer: structural-functional macromolecular perspectives and potential exosome-derived biomarkers
Qi, N., Wen, L., Li, S., & Feng, C. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02813-3
Integrative analysis of adenosine-related RNA modifications defines molecular subtypes of bladder cancer and identifies CES1 as a driver of tumor progression and immunotherapy resistance
Huo, X., Qi, J., ZHU, Y., Song, H., Han, W., & Wang, S. (2026) · BMC Cancer · doi:10.1186/s12885-026-15897-4
“More broadly, ECM stiffness can reshape immune infiltration and resistance through mechanosensing programs, supporting the possibility that CES1 linked stromal remodeling contributes to sustained WNT signaling and cytokine and JAK-STAT activity [93].”
A Tumor Microenvironment‐Derived CAF‐VEGF Model and Its Application in Biomarker Screening for HCC
Zheng, H., Tang, S., Shi, R., Zhu, Y., Geng, X., Huang, S., Zhang, R., Qu, X., Wan, H., Fang, C., et al. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70204
“…and mechanical regulation: they are principal producers of matrix proteins (e.g., collagens, elastin) that determine tissue stiffness and tension [21], and in 3D in vitro models breast cancer‐associated CAFs generate greater contractile forces than normal fibroblasts and markedly enhance…”
Peripheral nerve sheath tumors-on-a-chip: Next-generation platforms for mechanistic and therapeutic studies
Delaney, W. H., Faulkner, S. A., Lam, W. A., Boulis, N. M., Qiu, Y., & Lei, K. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100770
Surface-induced mechano-regulation of macrophages: emerging strategies for immunotherapy
Yang, J., Liu, R., Liu, X., & Song, Y. (2026) · Med-X · doi:10.1007/s44258-026-00083-9 · Cited by 1
3D Printed Bioelectronic Scaffolds for Impedance-based Cytotoxicity Monitoring of In Vitro Cancer ModelsPreprint
Okafor, S. S., Montgomery, S. K., Park, J., Liu, T., Safrega, M., Yu, J. S., O'Hare, C. P., Schab, A. M., Goestenkors, A. P., Espinoza, C. J. V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.07.719019
“In our prior work, this post processing treatment yielded a stiffness of ~40 kPa 49 , which falls within the range known to support tumor cell culture 38,67–69 .”
Exercise as a physiological “entosis switch”: a novel hypothesis for shifting cell-in-cell death from tumor-promoting to tumor-suppressive outcomes in epithelial cancers
Saghari, S., Kordi, N., & Omidali, F. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.111993
Glycolysis-driven cancer-associated fibroblasts shape T-Cell exclusion via the CXCL16–CXCR6 Axis: a metabolic-chemokine mechanism in tumor immunity
Liu, Y., Xiong, C., Huang, G., Xu, M., Li, J., Zhou, M., Liang, F., & Chen, R. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08160-8
“In contrast, when CD8 + T cells are sparse even at the tumor border, the dominant limitation often lies upstream: impaired vascular extravasation or a dense, stiff ECM that restricts interstitial migration [119, 120].”
Bioengineering CAR-T cells to function in hostile tumor microenvironments
Mahajna, S., Barhoum, R., Sabbah, A., Igescu, I.-M., & Mahameed, M. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.04.023
Fluid shear stress enhances pancreatic cancer motility through YAP activation
Deng, J., Lencioni, G., Pastore, A., Frampton, A. E., Deng, D., & Giovannetti, E. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02163-4
“Matrix hardness, traditionally considered a hallmark mechanical feature, plays a crucial role in affecting tumor metastasis and patient prognosis [4, 5].”
Mechanical Stiffening Promotes Growth, Invasion-Associated Phenotypes, and Reduced Selumetinib Sensitivity in 3D Plexiform Neurofibroma Cultures
Ji, K., Shi, C., Zhang, J., & Mattingly, R. R. (2026) · Cells · doi:10.3390/cells15100877 · Cited by 2
“Increased matrix rigidity can arise from enhanced deposition and crosslinking of collagen and other ECM components, often mediated by enzymes such as lysyl oxidase (LOX), and is frequently associated with tumor growth, fibrosis, or chronic tissue remodeling [24–26].”
Influential
Bone Marrow-Derived Mesenchymal Stem Cells Differentiate into Cancer-Associated Fibroblasts and Promote Tumor Growth in Renal Cell Carcinoma
Kitano, H., Yuge, R., Shikuma, H., Yukihiro, K., Hatayama, T., Nakano, Y., Tasaka, S., Okazaki, M., Nomura, N., Tasaka, R., et al. (2026) · Cancers · doi:10.3390/cancers18111716
Bidirectional crosstalk between cancer-associated fibroblasts and tumor immunity: shaping the microenvironment and response to immune checkpoint therapy
Wang, S. Q., Wang, D., Zhou, Y.-N., Li, W., Sun, G., Cao, L., Feng, C., Chen, Y., Shao, C., Gui, Q., et al. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00783-3 · Cited by 1
Emerging Lipid‐Based Nanoparticle Systems for Skin Cancer Therapy: Advancements, Challenges, and Future Perspectives
Negi, S., Kumar, S., Bharti, C., & Kumar, S. (2026) · ChemistrySelect · doi:10.1002/slct.202506355
Tumor infiltrating lymphocytes against solid tumors: current trends & perspectives
Liew, Z. M., Low, Y. S., Oh, K. C., Lee, Q. Y., Tye, G. J., Bayliss, R. W., Mai, C., Teo, M. Y. M., & In, L. L. A. (2026) · PeerJ · doi:10.7717/peerj.20969
“This shift enhances the cancer cell motility and invasiveness ( Zhang & Zhang, 2025 ).”
Neural crest cell signatures drive tumorigenesis in tuberous sclerosis complex and lymphangioleiomyomatosis
Unachukwu, U. J., Garcia, E. B., Rai, N., & D'Armiento, J. M. (2026) · JCI Insight · doi:10.1172/jci.insight.195013
“Decorin and lumican regulate collagen fibrillogenesis and growth-factor availability, whereas asporin enhances collagen cross-linking and matrix stiffness, collectively shaping ECM architecture and mechanotransduction (57).”
Canonical and emerging regulatory mechanisms of tissue remodeling: shared principles across organs and therapeutic opportunities
Wu, M., Han, Z., Wei, W., Niu, Y., Wang, H., Meng, F., & Wu, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1842892
“In ﬁ brotic tissues, tumors, and chronically injured organs, progressive ECM stiffening generates sustained mechanical cues that in ﬂ uence cell fate, activation states, and transcriptional programs, thereby profoundly altering cellular behavior (190).”
Modeling glioblastoma niche-by-niche: recent advancements in bioengineering of organotypic models of glioblastoma for precision medicine
Abedi, K., Sissoko, C. A., Pun, S., Kappagantula, S., Zucca, B., & Barrile, R. (2026) · Biofabrication · doi:10.1088/1758-5090/ae7832
“While the healthy human brain is mechanically soft, typically exhibiting stiffness values of 1 kPa or less along-side local variations [125, 126], the solid tumor mass in patients is often associated with significantly stiffer regions ranging between 7 and 27 kPa [127].”
3D nanoscaffolds: Bridging the gap between tumor microenvironment and therapy
Vakili‐Ghartavol, R., Nekounam, H., Sede, M. J. G., Safari, M., & Nazeri, N. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119630
Structural architecture of collagen and collagen-fibronectin networks is associated with the invasive behavior of liver cancer cells
Hayn, A., Matz‐Soja, M., Berg, T., & van Bömmel, F. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01235-0
Hydrogel microtumor arrays of patient melanoma recapitulate phenotypes and drug sensitivity
Liu, Y., Pawlush, M. L., Trynda, J., Lambert, E., Williams, C., Stenzel, M. H., Copland, J. A., & Kilian, K. A. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215015
Galectin-1 identifies a unique subpopulation of highly invasive glioblastoma cells and enables their migrationPreprint
Sanazzaro, T., Cotner, M., Arvinth, N., Brock, A., & Seidlits, S. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.15.732361
In vivo assessment of melanoma based on photoacoustic absorption and viscoelasticity imaging
Tan, Y., Jiang, A., Liang, Y., Zhang, H., Ma, Y., Dong, L., & Wang, P. (2026) · Biomedical Optics Express · doi:10.1364/boe.603217
“…migratory potential [20,21], whereas the increase in elasticity is driven by increased collagen deposition and crosslinking in the extracellular matrix (ECM), as well as dynamic matrix metalloproteinase-mediated remodeling, factors that drive tumor cells toward a more aggressive phenotype [22,23].”
Tumor-driven stabilization of CD8+ T cell exhaustion and implications for cancer immunotherapy
Thouenon, R., Ongaro, M., & Verdeil, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1862431
“Solid tumors develop extensive extra-cellular matrix (ECM) remodeling (Figure 1), leading to elevated stiffness, compressive and tensile forces, and altered mechanical stress pro ﬁ les that can directly impair immune cell function (40).”
Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research Agenda
Lonardo, A., Jamalinia, M., & Weiskirchen, R. (2026) · Livers · doi:10.3390/livers6050086
Advances in cell-derived extracellular matrix for 3D tumor modelling
Rodrigues, P. S., Henriques‐Pereira, M., Mano, J. F., & Gaspar, V. M. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103414 · Cited by 1
“These alterations reprogram the biochemical and biophysical properties of the ECM, thereby promoting tumor growth, invasion, and metastasis [2,3].”

Authors: Zhang, M., & Zhang, B.
Affiliations: China Three Gorges University (CN)
Corresponding author: Zhang, Bin
ORCID: Zhang, Meiling
Zhang, Bin
Venue: Experimental Hematology & Oncology
Publisher: Springer Science and Business Media LLC
Published: 2025-04-10
Volume: 14
Issue: 1
Pages: 54-54
ISSN: 2162-3619 (ISSN-L)
DOI: 10.1186/s40164-025-00647-2
PMC: PMC11984264
OpenAlex: W4409339209
Cited by: 269
References: 205
Citations by year: 2026: 199 · 2025: 70
FWCI: 32.05
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Experimental Hematology and Oncology (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords: extracellular matrix stiffness, tumor microenvironment, tumor progression, mechanotransduction, metastasis, drug resistance, angiogenesis, epithelial-mesenchymal transition, immune evasion, cancer stemness, metabolic reprogramming, genome stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks